Canada· CA-DIN-02247686
ATROVENT HFA
A ipratropium bromide product containing ipratropium bromide, registered in Canada by BOEHRINGER INGELHEIM (CANADA) LTD LTEE. The same ATC class is registered in 13 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Ipratropium bromide is registered in 13 of 19 countries.
Countries holding a registration under ATC R03BB01 (ipratropium bromide), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Ipratropium bromide · ATC R03BB01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- IPRATROPIUM BROMIDE
- Manufacturer
- BOEHRINGER INGELHEIM (CANADA) LTD LTEE
- Country
- Canada (CA)
- ATC code
- R03BB01
- ATC class
- Ipratropium bromide
- Defined daily dose
- 0.12 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
114 interactions on record for ipratropium bromide.
Graded by severity as the source publishes them — 114 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ipratropium bromide · interactions on record
114 records
- 114 moderate
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ipratropium bromide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAtrovent 20micrograms/dose AutohalerBoehringer Ingelheim Ltd
- United StatesAtroventBoehringer Ingelheim Pharmaceuticals, Inc.
- FinlandAtroventBoehringer Ingelheim International GmbH
- SwedenAtrovent 0,25 mg/ml Lösning för nebulisatorBoehringer Ingelheim International GmbH
- BelgiumAtronase 0.3 mg/mlSanofi Belgium
- FranceATROVENT 20 microgrammes/dose, solution pour inhalation en flacon pressuriséBOEHRINGER INGELHEIM FRANCE
- GermanyAtroventBoehringer Ingelheim Pharma Gmbh & Co. Kg
- NetherlandsAtrovent 20 microgram/dosis, aërosol, oplossingBoehringer Ingelheim B.V.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Atrovent - Dosieraerosol, Ipratropiumbromid Infectopharm
- Belgium · Atrovent, Atrovent Hfa
- Cyprus · Atrovent
- Czechia · Atrovent, Atrovent N
- Germany · Atrovent, Atrovent Ls
- Denmark · Atrovent, Ipratropiumbromid Teva
- Estonia · Atrovent N
- Spain · Atroaldo, Atrovent
- Finland · Atrovent, Atrovent Eco
- France · Atrovent, Atrovent Adultes
- United Kingdom (Northern Ireland) · Atrovent Inhaler Cfc-Free, Atrovent Udvs
- Greece · Atrovent, Broncovent
- Croatia · Atrovent, Atrovent N
- Hungary · Atrovent N
- Ireland · Atrovent 250 Udvs, Atrovent 500 Udvs
- Iceland · Atrovent, Lomuspray
- Italy · Atem, Nasipral
- Lithuania · Atrovent N
- Luxembourg · Atrovent, Atrovent Hfa
- Malta · Atroaldo, Atrovent Inhaler Cfc-Free
- Netherlands · Atrovent, Atrovent Unit Dose
- Norway · Atrovent, Ipraxa
- Poland · Atrodil, Atrovent
- Portugal · Atrovent, Atrovent Pa
- Romania · Ipravent Inhaler
- Sweden · Atrovent, Ipravent
- Slovakia · Atrovent N
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4cab9e22-7b9e-4eff-8c52-2bdd99ba112d GET /v1/drugs/4cab9e22-7b9e-4eff-8c52-2bdd99ba112d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02247686",
"form": "METERED-DOSE AEROSOL",
"class": "Human",
"routes": [
"INHALATION"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "R03BB01",
"schedule": [
"Prescription"
],
"drug_code": "71950",
"strengths": [
"20 MCG"
],
"ahfs_class": null,
"substances": [
"IPRATROPIUM BROMIDE"
],
"product_categorization": null
}See everything about ipratropium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.